Harrison Seth Loring (CIK 1404955) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (136,301 shares), Sell AKRO (148,063 shares), Sell AKRO (9,398 shares), Buy AKRO (9,398 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 136,301 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 148,063 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 9,398 | $0 |
| 2025-06-05 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 9,398 | $0 |
Source: SEC Form 4 filings · as of 2025-12-09